GSK-HZA107118

Study Sponsor: GSK

Study Title

A randomized, double-blind, placebo-controlled, parallel group study of once-daily inhaled Fluticasone Furoate Inhalation Powder for six weeks on the hypothalamic-pituitary-adrenocortical axis of children aged 5-11 years with asthma

Medicine or Vaccine (generic name)

fluticasone furoate

Sponsor Identification Number

HZA107118

Trial Registry Identification Number(#'s)

NCT02483975

Medical Condition

Asthma

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=107118

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02483975

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

March 2020